These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 31534520)

  • 1. Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets.
    Duinkerken S; Horrevorts SK; Kalay H; Ambrosini M; Rutte L; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y
    Theranostics; 2019; 9(20):5797-5809. PubMed ID: 31534520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
    Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
    J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses.
    Stolk DA; de Haas A; Vree J; Duinkerken S; Lübbers J; van de Ven R; Ambrosini M; Kalay H; Bruijns S; van der Vliet HJ; de Gruijl TD; van Kooyk Y
    Front Immunol; 2020; 11():990. PubMed ID: 32536918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.
    Flacher V; Tripp CH; Haid B; Kissenpfennig A; Malissen B; Stoitzner P; Idoyaga J; Romani N
    J Immunol; 2012 Mar; 188(5):2146-55. PubMed ID: 22291181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1.
    van den Berg LM; Cardinaud S; van der Aar AM; Sprokholt JK; de Jong MA; Zijlstra-Willems EM; Moris A; Geijtenbeek TB
    J Immunol; 2015 Aug; 195(4):1763-73. PubMed ID: 26170391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
    Unger WW; van Beelen AJ; Bruijns SC; Joshi M; Fehres CM; van Bloois L; Verstege MI; Ambrosini M; Kalay H; Nazmi K; Bolscher JG; Hooijberg E; de Gruijl TD; Storm G; van Kooyk Y
    J Control Release; 2012 May; 160(1):88-95. PubMed ID: 22366522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Herpesvirus 8 Infects and Replicates in Langerhans Cells and Interstitial Dermal Dendritic Cells and Impairs Their Function.
    Rappocciolo G; Jais M; Piazza PA; DeLucia DC; Jenkins FJ; Rinaldo CR
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and Functional Properties of Human Steady State CD14+ and CD1a+ Antigen Presenting Cells and Epidermal Langerhans Cells.
    Fehres CM; Bruijns SC; Sotthewes BN; Kalay H; Schaffer L; Head SR; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y
    PLoS One; 2015; 10(11):e0143519. PubMed ID: 26605924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ Delivery of Antigen to DC-SIGN(+)CD14(+) Dermal Dendritic Cells Results in Enhanced CD8(+) T-Cell Responses.
    Fehres CM; van Beelen AJ; Bruijns SCM; Ambrosini M; Kalay H; Bloois LV; Unger WWJ; Garcia-Vallejo JJ; Storm G; de Gruijl TD; Kooyk YV
    J Invest Dermatol; 2015 Sep; 135(9):2228-2236. PubMed ID: 25885805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
    Holla A; Skerra A
    Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH γ-1 class switching in response to gene gun vaccines.
    Stoecklinger A; Eticha TD; Mesdaghi M; Kissenpfennig A; Malissen B; Thalhamer J; Hammerl P
    J Immunol; 2011 Feb; 186(3):1377-83. PubMed ID: 21187444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors.
    Stoitzner P; Schaffenrath S; Tripp CH; Reider D; Komenda K; Del Frari B; Djedovic G; Ebner S; Romani N
    Exp Dermatol; 2014 Dec; 23(12):909-15. PubMed ID: 25346475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation.
    van de Ven R; van den Hout MF; Lindenberg JJ; Sluijter BJ; van Leeuwen PA; Lougheed SM; Meijer S; van den Tol MP; Scheper RJ; de Gruijl TD
    Blood; 2011 Sep; 118(9):2502-10. PubMed ID: 21750314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance.
    Flacher V; Tripp CH; Mairhofer DG; Steinman RM; Stoitzner P; Idoyaga J; Romani N
    EMBO Mol Med; 2014 Sep; 6(9):1191-204. PubMed ID: 25085878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C-type lectin receptor Langerin.
    Bellmann L; Strandt H; Zelle-Rieser C; Ortner D; Tripp CH; Schmid S; Rühl J; Cappellano G; Schaffenrath S; Prokopi A; Spoeck S; Seretis A; Del Frari B; Sigl S; Krapf J; Heufler C; Keler T; Münz C; Romani N; Stoitzner P
    Eur J Immunol; 2022 Nov; 52(11):1829-1841. PubMed ID: 34932821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus.
    Seneschal J; Jiang X; Kupper TS
    J Invest Dermatol; 2014 Mar; 134(3):686-694. PubMed ID: 24126845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of receptors binding HIV on dendritic cell subsets.
    Turville SG; Cameron PU; Handley A; Lin G; Pöhlmann S; Doms RW; Cunningham AL
    Nat Immunol; 2002 Oct; 3(10):975-83. PubMed ID: 12352970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
    Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P
    Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerin, the "Catcher in the Rye": an important receptor for pathogens on Langerhans cells.
    Stoitzner P; Romani N
    Eur J Immunol; 2011 Sep; 41(9):2526-9. PubMed ID: 21952811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.
    de Witte L; Nabatov A; Pion M; Fluitsma D; de Jong MA; de Gruijl T; Piguet V; van Kooyk Y; Geijtenbeek TB
    Nat Med; 2007 Mar; 13(3):367-71. PubMed ID: 17334373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.